Cargando…
Rescaling pain intensity measures for meta-analyses of analgesic medicines for low back pain appears justified: an empirical examination from randomised trials
OBJECTIVE: Meta-analyses of analgesic medicines for low back pain often rescale measures of pain intensity to use mean difference (MD) instead of standardised mean difference for pooled estimates. Although this improves clinical interpretability, it is not clear whether this method is justified. Our...
Autores principales: | Wewege, Michael A., Jones, Matthew D., Williams, Sam A., Kamper, Steven J., McAuley, James H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9636623/ https://www.ncbi.nlm.nih.gov/pubmed/36333665 http://dx.doi.org/10.1186/s12874-022-01763-x |
Ejemplares similares
-
Analgesic medicines for adults with low back pain: protocol for a systematic review and network meta-analysis
por: Wewege, Michael A., et al.
Publicado: (2020) -
Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis
por: Rizzo, Rodrigo R. N., et al.
Publicado: (2021) -
Development and validation of a screening tool to predict the risk of chronic low back pain in patients presenting with acute low back pain: a study protocol
por: Traeger, Adrian, et al.
Publicado: (2015) -
Estimating the Risk of Chronic Pain: Development and Validation of a Prognostic Model (PICKUP) for Patients with Acute Low Back Pain
por: Traeger, Adrian C., et al.
Publicado: (2016) -
Comparative effectiveness and safety of analgesic medicines for adults with acute non-specific low back pain: systematic review and network meta-analysis
por: Wewege, Michael A, et al.
Publicado: (2023)